Cargando…
Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity
Rhomboids are evolutionarily conserved serine proteases that cleave transmembrane proteins within the membrane. The increasing number of known rhomboid functions in prokaryotes and eukaryotes makes them attractive drug targets. Here, we describe structures of the Escherichia coli rhomboid GlpG in co...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690538/ https://www.ncbi.nlm.nih.gov/pubmed/23665170 http://dx.doi.org/10.1016/j.str.2013.03.013 |
_version_ | 1782274385224138752 |
---|---|
author | Vinothkumar, Kutti R. Pierrat, Olivier A. Large, Jonathan M. Freeman, Matthew |
author_facet | Vinothkumar, Kutti R. Pierrat, Olivier A. Large, Jonathan M. Freeman, Matthew |
author_sort | Vinothkumar, Kutti R. |
collection | PubMed |
description | Rhomboids are evolutionarily conserved serine proteases that cleave transmembrane proteins within the membrane. The increasing number of known rhomboid functions in prokaryotes and eukaryotes makes them attractive drug targets. Here, we describe structures of the Escherichia coli rhomboid GlpG in complex with β-lactam inhibitors. The inhibitors form a single bond to the catalytic serine and the carbonyl oxygen of the inhibitor faces away from the oxyanion hole. The hydrophobic N-substituent of β-lactam inhibitors points into a cavity within the enzyme, providing a structural explanation for the specificity of β-lactams on rhomboid proteases. This same cavity probably represents the S2′ substrate binding site of GlpG. We suggest that the structural changes in β-lactam inhibitor binding reflect the state of the enzyme at an initial stage of substrate binding to the active site. The structural insights from these enzyme-inhibitor complexes provide a starting point for structure-based design for rhomboid inhibitors. |
format | Online Article Text |
id | pubmed-3690538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Cell Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-36905382013-06-24 Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity Vinothkumar, Kutti R. Pierrat, Olivier A. Large, Jonathan M. Freeman, Matthew Structure Short Article Rhomboids are evolutionarily conserved serine proteases that cleave transmembrane proteins within the membrane. The increasing number of known rhomboid functions in prokaryotes and eukaryotes makes them attractive drug targets. Here, we describe structures of the Escherichia coli rhomboid GlpG in complex with β-lactam inhibitors. The inhibitors form a single bond to the catalytic serine and the carbonyl oxygen of the inhibitor faces away from the oxyanion hole. The hydrophobic N-substituent of β-lactam inhibitors points into a cavity within the enzyme, providing a structural explanation for the specificity of β-lactams on rhomboid proteases. This same cavity probably represents the S2′ substrate binding site of GlpG. We suggest that the structural changes in β-lactam inhibitor binding reflect the state of the enzyme at an initial stage of substrate binding to the active site. The structural insights from these enzyme-inhibitor complexes provide a starting point for structure-based design for rhomboid inhibitors. Cell Press 2013-06-04 /pmc/articles/PMC3690538/ /pubmed/23665170 http://dx.doi.org/10.1016/j.str.2013.03.013 Text en © 2013 ELL & Excerpta Medica. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Short Article Vinothkumar, Kutti R. Pierrat, Olivier A. Large, Jonathan M. Freeman, Matthew Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity |
title | Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity |
title_full | Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity |
title_fullStr | Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity |
title_full_unstemmed | Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity |
title_short | Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity |
title_sort | structure of rhomboid protease in complex with β-lactam inhibitors defines the s2′ cavity |
topic | Short Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690538/ https://www.ncbi.nlm.nih.gov/pubmed/23665170 http://dx.doi.org/10.1016/j.str.2013.03.013 |
work_keys_str_mv | AT vinothkumarkuttir structureofrhomboidproteaseincomplexwithblactaminhibitorsdefinesthes2cavity AT pierratoliviera structureofrhomboidproteaseincomplexwithblactaminhibitorsdefinesthes2cavity AT largejonathanm structureofrhomboidproteaseincomplexwithblactaminhibitorsdefinesthes2cavity AT freemanmatthew structureofrhomboidproteaseincomplexwithblactaminhibitorsdefinesthes2cavity |